AUTOLOGOUS CYTOKINE-INDUCED KILLER (CIK) IMMUNOTHERAPY IN A CASE OF DISSEMINATED TUBERCULOSIS

被引：0
作者：
Xu, Ping [1 ]
Xu, Jun-Chi [1 ]
Chen, Xin-Nian [1 ]
Ye, Zhi-Jian [1 ]
Wu, Mei-Ying [1 ]
机构：
[1] Fifth Peoples Hosp Suzhou, Suzhou 215000, Jiangsu, Peoples R China
来源：
SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES | 2015年 / 32卷 / 01期
关键词：
CIK; disseminated tuberculosi; immunotherapy; PHASE-I; CELLS; LYMPHOMA; TRIAL; VIVO;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
A 23-year-old woman had dry cough, fever and chest tightness for 1 months. Through thoracic CT scan and serological examination, the patient was clinically diagnosed as disseminated tuberculosis. she was given anti-tuberculosis therapy combined with autologous cytokine-induced killer (CIK) immunotherapy. Through the close follow-ups we found that after immunotherapy Her condition would have a swift improvement and she do not appear liver damage after a large doses of antibiotic therapy. In conclusion, adjuvant autologous CIK immunotherapy is an effective approach for disseminated tuberculosis.
引用
收藏
页码：83 / 86
页数：4
相关论文
共 13 条
  • [1] Furuhashi K, 2012, KEKKAKU, V87, P1
  • [2] A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma
    Leemhuis, T
    Wells, S
    Scheffold, C
    Edinger, M
    Negrin, RS
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (03) : 181 - 187
  • [3] Li Hui, 2005, Zhonghua Yi Xue Za Zhi, V85, P3134
  • [4] Review of Chinese clinical trials on CIK cell treatment for malignancies
    Li, Xiao-Dong
    Xu, Bin
    Wu, Jun
    Ji, Mei
    Xu, Bei-Hua
    Jiang, Jing-Ting
    Wu, Chang-Ping
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (02) : 102 - 108
  • [5] Ex vivo purging of stem cell autografts using cytotoxic cells
    Maki, G
    [J]. JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (04): : 545 - 551
  • [6] Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors
    Mesiano, Giulia
    Todorovic, Maja
    Gammaitoni, Loretta
    Leuci, Valeria
    Diego, Lidia Giraudo
    Carnevale-Schianca, Fabrizio
    Fagioli, Franca
    Piacibello, Wanda
    Aglietta, Massimo
    Sangiolo, Dario
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (06) : 673 - 684
  • [7] Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma
    Schmidt-Wolf, IGH
    Finke, S
    Trojaneck, B
    Denkena, A
    Lefterova, P
    Schwella, N
    Heuft, HG
    Prange, G
    Korte, M
    Takeya, M
    Dorbic, T
    Neubauer, A
    Wittig, B
    Huhn, D
    [J]. BRITISH JOURNAL OF CANCER, 1999, 81 (06) : 1009 - 1016
  • [8] USE OF A SCID MOUSE HUMAN LYMPHOMA MODEL TO EVALUATE CYTOKINE-INDUCED KILLER-CELLS WITH POTENT ANTITUMOR CELL-ACTIVITY
    SCHMIDTWOLF, IGH
    NEGRIN, RS
    KIEM, HP
    BLUME, KG
    WEISSMAN, IL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) : 139 - 149
  • [9] Shi M, 2004, WORLD J GASTROENTERO, V10, P1146
  • [10] SURCEL HM, 1994, IMMUNOLOGY, V81, P171
12